Literature DB >> 26558634

Iron Loading Selectively Increases Hippocampal Levels of Ubiquitinated Proteins and Impairs Hippocampus-Dependent Memory.

Luciana Silva Figueiredo1, Betânia Souza de Freitas1, Vanessa Athaíde Garcia1, Vinícius Ayub Dargél1, Luiza Machado Köbe1, Luiza Wilges Kist2,3, Maurício Reis Bogo2,3, Nadja Schröder4.   

Abstract

Alterations of brain iron levels have been observed in a number of neurodegenerative disorders. We have previously demonstrated that iron overload in the neonatal period results in severe and persistent memory deficits in the adulthood. Protein degradation mediated by the ubiquitin-proteasome system (UPS) plays a central regulatory role in several cellular processes. Impairment of the UPS has been implicated in the pathogenesis of neurodegenerative disorders. Here, we examined the effects of iron exposure in the neonatal period (12th-14th day of postnatal life) on the expression of proteasome β-1, β-2, and β-5 subunits, and ubiquitinated proteins in brains of 15-day-old rats, to evaluate the immediate effect of the treatment, and in adulthood to assess long-lasting effects. Two different memory types, emotionally motivated conditioning and object recognition were assessed in adult animals. We found that iron administered in the neonatal period impairs both emotionally motivated and recognition memory. Polyubiquitinated protein levels were increased in the hippocampus, but not in the cortex, of adult animals treated with iron. Gene expression of subunits β1 and β5 was affected by age, being higher in the early stages of development in the hippocampus, accompanied by an age-related increase in polyubiquitinated protein levels in adults. In the cortex, gene expression of the three proteasome subunits was significantly higher in adulthood than in the neonatal period. These findings suggest that expression of proteasome subunits and activity are age-dependently regulated. Iron exposure in the neonatal period produces long-lasting harmful effects on the UPS functioning, which may be related with iron-induced memory impairment.

Entities:  

Keywords:  Iron; Memory; Neurodegenerative disorders; Ubiquitin-proteasome system; β-proteasome subunits

Mesh:

Substances:

Year:  2015        PMID: 26558634     DOI: 10.1007/s12035-015-9514-6

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  54 in total

Review 1.  The 26S proteasome: a molecular machine designed for controlled proteolysis.

Authors:  D Voges; P Zwickl; W Baumeister
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

2.  The ubiquitin-proteasome cascade is required for mammalian long-term memory formation.

Authors:  M Lopez-Salon; M Alonso; M R Vianna; H Viola; T Mello e Souza; I Izquierdo; J M Pasquini; J H Medina
Journal:  Eur J Neurosci       Date:  2001-12       Impact factor: 3.386

3.  The role of hippocampal iron concentration and hippocampal volume in age-related differences in memory.

Authors:  Karen M Rodrigue; Ana M Daugherty; E Mark Haacke; Naftali Raz
Journal:  Cereb Cortex       Date:  2012-05-29       Impact factor: 5.357

Review 4.  The ubiquitin system.

Authors:  A Hershko; A Ciechanover
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

5.  Possible contribution of proteins of Bcl-2 family in neuronal death following transient global brain ischemia.

Authors:  Ivana Pilchova; Katarina Klacanova; Maria Chomova; Zuzana Tatarkova; Dusan Dobrota; Peter Racay
Journal:  Cell Mol Neurobiol       Date:  2014-09-04       Impact factor: 5.046

6.  Cannabidiol normalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: implications for neuroprotection.

Authors:  Vanessa Kappel da Silva; Betânia Souza de Freitas; Arethuza da Silva Dornelles; Laura Roesler Nery; Lucio Falavigna; Rafael Dal Ponte Ferreira; Maurício Reis Bogo; Jaime Eduardo Cecílio Hallak; Antônio Waldo Zuardi; José Alexandre S Crippa; Nadja Schröder
Journal:  Mol Neurobiol       Date:  2013-07-28       Impact factor: 5.590

7.  Lipopolysaccharide-induced neuroinflammation leads to the accumulation of ubiquitinated proteins and increases susceptibility to neurodegeneration induced by proteasome inhibition in rat hippocampus.

Authors:  Cristina Pintado; María P Gavilán; Elena Gavilán; Luisa García-Cuervo; Antonia Gutiérrez; Javier Vitorica; Angélica Castaño; Rosa M Ríos; Diego Ruano
Journal:  J Neuroinflammation       Date:  2012-05-04       Impact factor: 8.322

8.  Antioxidant effects of selegiline in oxidative stress induced by iron neonatal treatment in rats.

Authors:  Patrícia Budni; Maria Noemia Martins de Lima; Manuela Polydoro; José Cláudio Fonseca Moreira; Nadja Schroder; Felipe Dal-Pizzol
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 4.414

9.  Proteasome activator enhances survival of Huntington's disease neuronal model cells.

Authors:  Hyemyung Seo; Kai-Christian Sonntag; Woori Kim; Elena Cattaneo; Ole Isacson
Journal:  PLoS One       Date:  2007-02-28       Impact factor: 3.240

10.  Depletion of 26S proteasomes in mouse brain neurons causes neurodegeneration and Lewy-like inclusions resembling human pale bodies.

Authors:  Lynn Bedford; David Hay; Anny Devoy; Simon Paine; Des G Powe; Rashmi Seth; Trevor Gray; Ian Topham; Kevin Fone; Nooshin Rezvani; Maureen Mee; Tim Soane; Robert Layfield; Paul W Sheppard; Ted Ebendal; Dmitry Usoskin; James Lowe; R John Mayer
Journal:  J Neurosci       Date:  2008-08-13       Impact factor: 6.167

View more
  8 in total

1.  Mitoferrin-1 is required for brain energy metabolism and hippocampus-dependent memory.

Authors:  Lisa Baldauf; Thomas Endres; Johannes Scholz; Elmar Kirches; Diane M Ward; Volkmar Lessmann; Katrin Borucki; Christian Mawrin
Journal:  Neurosci Lett       Date:  2019-09-26       Impact factor: 3.046

2.  The Tyrosine Phosphatase STEP Is Involved in Age-Related Memory Decline.

Authors:  David Castonguay; Julien Dufort-Gervais; Caroline Ménard; Manavi Chatterjee; Rémi Quirion; Bruno Bontempi; Jay S Schneider; Amy F T Arnsten; Angus C Nairn; Christopher M Norris; Guylaine Ferland; Erwan Bézard; Pierrette Gaudreau; Paul J Lombroso; Jonathan Brouillette
Journal:  Curr Biol       Date:  2018-03-22       Impact factor: 10.834

3.  Neuronal activity regulated pentraxin (narp) and GluA4 subunit of AMPA receptor may be targets for fluoxetine modulation.

Authors:  Isabella A Heinrich; Andiara E Freitas; Ingrid A V Wolin; Ana Paula M Nascimento; Roger Walz; Ana Lúcia S Rodrigues; Rodrigo B Leal
Journal:  Metab Brain Dis       Date:  2021-02-02       Impact factor: 3.584

4.  Iron Overload Impairs Autophagy: Effects of Rapamycin in Ameliorating Iron-Related Memory Deficits.

Authors:  Vanise Hallas Uberti; Betânia Souza de Freitas; Patrícia Molz; Elke Bromberg; Nadja Schröder
Journal:  Mol Neurobiol       Date:  2019-10-29       Impact factor: 5.590

5.  Postnatal Iron Supplementation with Ferrous Sulfate vs. Ferrous Bis-Glycinate Chelate: Effects on Iron Metabolism, Growth, and Central Nervous System Development in Sprague Dawley Rat Pups.

Authors:  Shasta McMillen; Bo Lönnerdal
Journal:  Nutrients       Date:  2021-04-22       Impact factor: 5.717

Review 6.  Impact of high iron intake on cognition and neurodegeneration in humans and in animal models: a systematic review.

Authors:  Sonal Agrawal; Kiersten L Berggren; Eileen Marks; Jonathan H Fox
Journal:  Nutr Rev       Date:  2017-06-01       Impact factor: 7.110

7.  Antiapoptotic effects of cannabidiol in an experimental model of cognitive decline induced by brain iron overload.

Authors:  Vanessa Kappel da Silva; Betânia Souza de Freitas; Rebeca Carvalho Lacerda Garcia; Ricardo Tavares Monteiro; Jaime Eduardo Hallak; Antônio Waldo Zuardi; José Alexandre S Crippa; Nadja Schröder
Journal:  Transl Psychiatry       Date:  2018-09-03       Impact factor: 6.222

Review 8.  Current understanding of metal ions in the pathogenesis of Alzheimer's disease.

Authors:  Lu Wang; Ya-Ling Yin; Xin-Zi Liu; Peng Shen; Yan-Ge Zheng; Xin-Rui Lan; Cheng-Biao Lu; Jian-Zhi Wang
Journal:  Transl Neurodegener       Date:  2020-04-03       Impact factor: 8.014

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.